Li Yang | |
|---|---|
 | |
| Alma mater | Vanderbilt University |
| Scientific career | |
| Fields | Cancer biology |
| Institutions | National Cancer Institute |
| Doctoral advisor | David Carbone |
Li Yang is an American biologist researching how inflammation in the premetastatic environment modifies cancer cell colonization. She is a senior investigator and head of the tumor microenvironment section at the National Cancer Institute.
Yang received a Ph.D. in the Department of Cancer Biology at Vanderbilt University, under the mentorship of David Carbone . Her dissertation research focused on COX-2 pathway in tumor progression, immunosuppression, and the contribution of host myeloid cells to tumor blood vessel formation. She investigated TGF-β regulation of inflammation and tumor microenvironment as a postdoctoral researcher research with Harold L. Moses. [1] [2]
Yang joined the National Cancer Institute (NCI) in 2009 and was tenured in 2016. She a senior investigator with a research program devoted to understanding the molecular mechanisms underlying tumor-stroma interaction during metastatic process. Her studies demonstrate that cancer-associated inflammation is critical in the functional switch of TGF-β from a suppressor to a promoter. Her team is currently investigating how myeloid-specific TGF-β signaling modulates host inflammation/immune response in cancer and other pathological conditions. [1] [2]
As head of the tumor microenvironment Section, Yang is interested in how inflammation in the premetastatic environment modifies cancer cell colonization. Her research approaches include cellular and molecular biology, cancer biology, immunology, as well as integrated genomic-wide genetic and epigenetic approaches. [1]
Yang is a recipient of the Federal Technology Transfer Award, co-recipient of FLEX Program Awards for Principal Investigators, CCR, NCI, as well as U.S.-China Biomedical Collaborative Research Grant award. [1] [2]
The regulatory T cells (Tregs or Treg cells), formerly known as suppressor T cells, are a subpopulation of T cells that modulate the immune system, maintain tolerance to self-antigens, and prevent autoimmune disease. Treg cells are immunosuppressive and generally suppress or downregulate induction and proliferation of effector T cells. Treg cells express the biomarkers CD4, FOXP3, and CD25 and are thought to be derived from the same lineage as naïve CD4+ cells. Because effector T cells also express CD4 and CD25, Treg cells are very difficult to effectively discern from effector CD4+, making them difficult to study. Research has found that the cytokine transforming growth factor beta (TGF-β) is essential for Treg cells to differentiate from naïve CD4+ cells and is important in maintaining Treg cell homeostasis.
Mothers against decapentaplegic homolog 3 also known as SMAD family member 3 or SMAD3 is a protein that in humans is encoded by the SMAD3 gene.
Elaine V. Fuchs is an American cell biologist famous for her work on the biology and molecular mechanisms of mammalian skin and skin diseases, who helped lead the modernization of dermatology. Fuchs pioneered reverse genetics approaches, which assess protein function first and then assess its role in development and disease. In particular, Fuchs researches skin stem cells and their production of hair and skin. She is an investigator at the Howard Hughes Medical Institute and the Rebecca C. Lancefield Professor of Mammalian Cell Biology and Development at The Rockefeller University.
OX-2 membrane glycoprotein, also named CD200 is a human protein encoded by the CD200 gene. CD200 gene is in human located on chromosome 3 in proximity to genes encoding other B7 proteins CD80/CD86. In mice CD200 gene is on chromosome 16.
Joan Massagué, is a Spanish biologist and the current director of the Sloan Kettering Institute at Memorial Sloan Kettering Cancer Center. He is also an internationally recognized leader in the study of both cancer metastasis and growth factors that regulate cell behavior, as well as a professor at the Weill Cornell Graduate School of Medical Sciences.
The tumor microenvironment (TME) is the environment around a tumor, including the surrounding blood vessels, immune cells, fibroblasts, signaling molecules and the extracellular matrix (ECM). The tumor and the surrounding microenvironment are closely related and interact constantly. Tumors can influence the microenvironment by releasing extracellular signals, promoting tumor angiogenesis and inducing peripheral immune tolerance, while the immune cells in the microenvironment can affect the growth and evolution of cancerous cells.
Myeloid-derived suppressor cells (MDSC) are a heterogeneous group of immune cells from the myeloid lineage.
Kandice Tanner is a Trinidad and Tobago biophysicist researching the metastatic traits that allow tumor cells to colonize secondary organs. She is a Senior Investigator at the National Cancer Institute, where she is head of the Tissue morphodynamics section.
Esta Sterneck is an Austrian molecular biologist researching the functions of the C/EBPδ][CEBPD transcription factor as tumor suppressor as well as tumor promoter in breast epithelial cells and cells of the tumor microenvironment. She is a senior investigator and head of the molecular mechanisms in development section at the National Cancer Institute.
Kathrin Muegge is a German physician and molecular biologist researching chromatin organization during embryonic development and in tumor progression. She is a senior investigator and head of the epigenetics section at the Frederick National Laboratory for Cancer Research.
Christine Campo Alewine is an American oncologist and biologist researching immunotoxin therapeutics in pancreatic cancer. She is an investigator at the National Cancer Institute.
Silvana Romina Goldszmid is an Argentine-American biologist researching tumor immunology. She is an NIH Stadtman Investigator at the National Cancer Institute.
Rosandra N. Kaplan is an American pediatric oncologist and scientist specialized in translational and clinical research on the mechanisms of cancer spread. She is a principal investigator and head of the tumor microenvironment and metastasis branch at the National Cancer Institute.
Natalie Porat-Shliom is an Israeli-American cell biologist and microscopist specialized in intravital microscopy to research mitochondrial structure. She is a NIH Stadtman Investigator and head of the cell biology and imaging section at the National Cancer Institute.
Ying E. Zhang is a Chinese-American biochemist specialized in TGF-beta signaling and functions of ubiquitin E3 ligase Smurfs to better understand cancer cells and metastasis. She is a senior investigator in the Laboratory of Cellular and Molecular Biology at the National Cancer Institute.
Carol Jeanne Thiele is an American microbiologist and cancer researcher specialized in the development of novel therapeutic strategies for pediatric tumors. She is chief of the cell and molecular biology section at the National Cancer Institute. She is a founding editor of the journal Cell Death & Differentiation.
Xiaohong Rose Yang is an American biomedical scientist researching the genetics of dysplastic nevus syndrome and chordoma, and etiologic heterogeneity of breast cancer. She is a senior investigator at the National Cancer Institute. Yang leads breast cancer studies in mainland China, Hong Kong, and Malaysia.
Bríd M. Ryan is an Irish biomedical scientist and cancer researcher. She was an investigator at the National Cancer Institute from 2013 to 2021.
Laufey Thora Ámundadóttir is an Icelandic cell biologist and geneticist who researches pancreatic cancer. She is a senior investigator in the laboratory of translational genomics at the National Cancer Institute. She was head of the division of cancer genetics at deCODE genetics from 1998 to 2007.
Bing Li is an immunologist, researcher, and academic. He is an Endowed Professor for Cancer Immunology, a professor of Pathology at the University of Iowa, and the Director of Iowa Cancer and Obesity Initiative. He is also the founder of BMImmune Inc.
This article incorporates text from this source, which is in the public domain . This article incorporates text from this source, which is in the public domain . This article incorporates public domain material from websites or documents of the National Institutes of Health.
Media related to Li Yang (biologist) at Wikimedia Commons| Authority control databases: Academics |
|---|
